Gleason Group, Inc. Viatris Inc Transaction History
Gleason Group, Inc.
- $567 Million
- Q4 2024
A detailed history of Gleason Group, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Gleason Group, Inc. holds 34 shares of VTRS stock, worth $390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 34
-0.0%
Holding current value
$390
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VTRS
# of Institutions
1,135Shares Held
987MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.63 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.06 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$732 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$718 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$674 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...